Calculate your SIP ReturnsExplore

Kronox Lab Sciences IPO Subscribed 117.25x on Day 3

11 June 20243 mins read by Angel One
Kronox Lab Sciences IPO subscribed 117.25x. The public issue subscribed 54.23x in retail, 89.03 in QIB, and 301.92x in NII.
Kronox Lab Sciences IPO Subscribed 117.25x on Day 3
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

The Kronox Lab Sciences IPO was closed on June 05, 2024. The allotment for the Kronox Lab Sciences IPO is expected to be finalised on June 6, 2024. The Kronox Lab Sciences IPO will list on BSE and NSE, with a tentative listing date fixed as June 10, 2024.

The IPO price range for Kronox Lab Sciences is ₹129 to ₹136 per share. The minimum lot size required for an application is 110 shares. Retail investors are required to invest a minimum of ₹14,960. For both sNII and bNII, the minimum lot size investment is ₹2,09,440 for 14 lots (1,540 shares) and ₹10,02,320 for 67 lots (7,370 shares).

Day Wise Subscription

  • On the 1st day of subscription, i.e., June 03, 2024, the IPO was subscribed 11.15x. QIBs subscribed 1.11x, NIIs 20x, and retail investors subscribed 13.09x.
  • On the 2nd day of subscription, i.e., June 04, 2024, Kronox Lab Sciences IPO subscribed 24.63x. The public issue subscribed 24.63x in retail, 3.39x in QIB, and 52.97x in NII.
  • On the last day of subscription, i.e., June 05, 2024, the IPO subscribed 117.25x. The public issue subscribed 54.23x in retail, 89.03 in QIB, and 301.92x in NII

Grey Market Premium

Kronox Lab Sciences IPO’s last GMP is ₹40. With a price band of ₹136.00, Kronox Lab Sciences IPO’s estimated listing price is ₹176 (cap price + today’s GMP). The expected percentage gain/loss per share is 29.41%.

About Kronox Lab Sciences Limited

Incorporated in 2008, Kronox Lab Sciences Limited manufactures high-purity specialty fine chemicals for diverse end-user industries. The company’s High-Purity Specialty Fine Chemicals are used in various applications, such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.

Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link
Open Free Demat Account!
Enjoy Zero Brokerage on Stock Investments.